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Some Familial Isolated Primary Hyperparathyroidism 
(FIHP) families have been mapped to this locus. 
Inheritance 
Autosomal dominant, early onset, highly penetrant, 
reported in caucasians and Japanese so far. 
Clinics 
Note 
- Phenotypic spectrum variable; 
- Growth: normal; 
- Head: normal; 
- Skin: normal; 
- Hyperparathyroidism, jaw tumors, and kidney cysts; 
- Hyperparathyroidism develops in about 95% of 
affected individuals due to parathyroid adenomas 
which can occur singley or multiply, with some 
patients undergoing several parathyroidectomies over 
the course of their lives; 
- Parathyroid carcinoma develops in about 5% of 
patients (compare to 1 in 5 million in the general 
population); 
- The jaw tumors consist of trabeculae of woven bone 
set in a cytologically bland fibrocellular stroma; 
- About 50% develop fibro-osseous tumors of the 
maxilla or mandible, which may recur and are 
independent of the course of the parathyroid adenomas; 
- Some families display an increased risk of developing 
kidney cysts (nephroblastomas or hamartomas) or adult 
Wilms tumors; 
- Surgical removal of neoplastic tissues; 
- Regular serum calcium level screening is a cost 
effective method to catch the development of 
parathyroid adenomas at an early stage; 
- Dental x-rays are not recommended; may increase 
risk of development of jaw tumors. 
Evolution 
Usually develop parathyroid adenomas by age 40 years 




Cytogenetics of cancer 
Loss of heterozygosity of all of chromosome 1 has 
been seen in some HPT-JT parathyroid adenomas. 
Genes involved and proteins 
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